Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 2
1984 3
1985 6
1986 25
1987 15
1988 17
1989 17
1990 17
1991 27
1992 29
1993 28
1994 28
1995 30
1996 35
1997 46
1998 40
1999 37
2000 35
2001 27
2002 36
2003 36
2004 41
2005 29
2006 34
2007 46
2008 33
2009 33
2010 16
2011 23
2012 27
2013 25
2014 16
2015 19
2016 19
2017 18
2018 23
2019 13
2020 23
2021 28
2022 30
2023 16
2024 30
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,030 results

Results by year

Filters applied: . Clear all
Page 1
Terazosin.
[No authors listed] [No authors listed] 2024 Dec 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2024 Dec 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000707 Free Books & Documents. Review.
Because no information is available on the use of terazosin during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant....
Because no information is available on the use of terazosin during breastfeeding, an alternate drug may be preferred, especially whil …
[Terazosin].
Schäfers RF, Michel MC. Schäfers RF, et al. Dtsch Med Wochenschr. 1998 Apr 9;123(15):459-60. doi: 10.1055/s-0029-1233226. Dtsch Med Wochenschr. 1998. PMID: 9581161 Review. German. No abstract available.
Terazosin for benign prostatic hyperplasia.
Wilt TJ, Howe RW, Rutks IR, MacDonald R. Wilt TJ, et al. Cochrane Database Syst Rev. 2002;(4):CD003851. doi: 10.1002/14651858.CD003851. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2011 Sep 07;(9):CD003851. doi: 10.1002/14651858.CD003851.pub2. PMID: 12519611 Updated. Review.
Peak urine flow rates improved greater with terazosin (22%), than placebo (11%) and finasteride (15%) but did not differ significantly from the other alpha-blockers. The percentage of men discontinuing terazosin was comparable to men receiving placebo and finasterid …
Peak urine flow rates improved greater with terazosin (22%), than placebo (11%) and finasteride (15%) but did not differ significantl …
Terazosin Stimulates Pgk1 to Remedy Gastrointestinal Disorders.
Liu J, Zhao W, Li C, Wu T, Han L, Hu Z, Li X, Zhou J, Chen X. Liu J, et al. Int J Mol Sci. 2021 Dec 30;23(1):416. doi: 10.3390/ijms23010416. Int J Mol Sci. 2021. PMID: 35008842 Free PMC article.
The current study was designed to explore the anti-oxidation, anti-inflammation, anti-cell death properties of terazosin, an alpha-adrenergic receptor antagonist, in vivo and in vitro. Our results indicate that terazosin dramatically activates Pgk1, and upregulates …
The current study was designed to explore the anti-oxidation, anti-inflammation, anti-cell death properties of terazosin, an alpha-ad …
Terazosin: a new alpha adrenoceptor blocking drug.
Achari R, Laddu A. Achari R, et al. J Clin Pharmacol. 1992 Jun;32(6):520-3. doi: 10.1177/009127009203200605. J Clin Pharmacol. 1992. PMID: 1353083 Review.
Greater water solubility facilitates intravenous formulation, and longer half-life allows once-daily administration of terazosin. Terazosin is effective in lowering blood pressure and has a beneficial effect on plasma lipid profile. The major advantage of terazos …
Greater water solubility facilitates intravenous formulation, and longer half-life allows once-daily administration of terazosin. …
Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
Titmarsh S, Monk JP. Titmarsh S, et al. Drugs. 1987 May;33(5):461-77. doi: 10.2165/00003495-198733050-00003. Drugs. 1987. PMID: 2885169 Review.
Terazosin is a post-synaptic alpha 1-adrenoceptor antagonist with a similar pharmacodynamic profile to prazosin. ...In the few patients with congestive heart failure studied, terazosin produced an increase in cardiac output with a reduction in ventricular filling pr …
Terazosin is a post-synaptic alpha 1-adrenoceptor antagonist with a similar pharmacodynamic profile to prazosin. ...In the few patien …
Terazosin: a new long-acting alpha 1-adrenergic antagonist for hypertension.
Frishman WH, Eisen G, Lapsker J. Frishman WH, et al. Med Clin North Am. 1988 Mar;72(2):441-8. doi: 10.1016/s0025-7125(16)30778-7. Med Clin North Am. 1988. PMID: 2894488 Review.
Terazosin is a new long-acting, selective alpha 1-adrenergic antagonist. Its pharmacokinetic and pharmacodynamic profiles are similar to those of prazosin, but terazosin has a half-life three to four times longer. This allows once daily dosing of terazosin an …
Terazosin is a new long-acting, selective alpha 1-adrenergic antagonist. Its pharmacokinetic and pharmacodynamic profiles are similar …
Terazosin in the treatment of benign prostatic hyperplasia: the United States experience.
Lepor H, Laddu A. Lepor H, et al. Br J Urol. 1992 Nov;70 Suppl 1:2-9. doi: 10.1111/j.1464-410x.1992.tb15860.x. Br J Urol. 1992. PMID: 1281728 Review.
The outcome measures used to assess the efficacy of terazosin in BPH includes Boyarsky symptom scores and uroflowmetry. The total Boyarsky symptom score decreased 55% and the peak urinary flow increased 47% following terazosin therapy in the cumulative open-label an …
The outcome measures used to assess the efficacy of terazosin in BPH includes Boyarsky symptom scores and uroflowmetry. The total Boy …
Terazosin for hypertension.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1987 Dec 18;29(755):112-3. Med Lett Drugs Ther. 1987. PMID: 2891021 Clinical Trial. No abstract available.
Terazosin attenuates abdominal aortic aneurysm formation by downregulating Peg3 expression to inhibit vascular smooth muscle cell apoptosis and senescence.
Wei X, Li Y, Jiang T, Luo P, Dai Y, Wang Q, Xu M, Yan J, Li Y, Gao J, Liu L, Zhang C, Liu Y. Wei X, et al. Eur J Pharmacol. 2024 Apr 5;968:176397. doi: 10.1016/j.ejphar.2024.176397. Epub 2024 Feb 7. Eur J Pharmacol. 2024. PMID: 38331337 Free article.
Despite the severity of AAA, effective drugs for treatment are scarce. At low doses, terazosin (TZ) exerts antiapoptotic and anti-inflammatory effects in several diseases, but its potential to protect against AAA remains unexplored. ...
Despite the severity of AAA, effective drugs for treatment are scarce. At low doses, terazosin (TZ) exerts antiapoptotic and anti-inf …
1,030 results